01.03.2013 Views

Understanding Clinical Trial Design - Research Advocacy Network

Understanding Clinical Trial Design - Research Advocacy Network

Understanding Clinical Trial Design - Research Advocacy Network

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

UNDERSTANDING CLINICAL TRIAL DESIGN: A TUTORIAL FOR RESEARCH ADVOCATES<br />

Bias Bias in a sample is the presence or influence of any<br />

factor that causes the population or process being<br />

sampled to appear different from what it actually is. Bias<br />

is introduced into a sample when data are collected<br />

without regard to key factors.<br />

Biomarker A characteristic (e.g., protein, gene) that is objectively<br />

measured and evaluated from a biological sample (e.g.,<br />

tissue, blood) as an indicator of normal biological<br />

processes, pathogenic processes, or pharmacologic<br />

responses to a therapeutic intervention.<br />

Blinding A procedure in which one or more parties to the trial are<br />

kept unaware of the treatment assignment. Double (or<br />

triple) blinding means that investigators and/or health<br />

care providers, in addition to patients, are unaware of<br />

the treatment assignments.<br />

<strong>Clinical</strong> Endpoint An occurrence that measures the study hypothesis. It is<br />

often a characteristic or variable that reflects how a<br />

patient feels, functions, or survives, and used to measure<br />

whether a treatment is effective.<br />

• Primary—what a trial is designed to assess<br />

• Secondary—other endpoints of interest<br />

<strong>Clinical</strong> <strong>Trial</strong> A type of research study that assesses medical questions<br />

in people. These studies often test new methods of<br />

screening, prevention, diagnosis, or treatment of a<br />

disease.<br />

Comparison Group; The treatment received by the comparison or control<br />

Control Intervention group, often a placebo. In cancer trials, the control<br />

or Control Treatment intervention is usually the current standard of care.<br />

Confounding In research design, the problem that arises when two or<br />

more causal variables , often an independent variable and<br />

an extraneous variable, are not properly controlled, so<br />

that their separate effects on the outcome measure can<br />

not be disentangled.<br />

Comparison or A group of patients who are not treated with the experi-<br />

Control Group mental intervention (e.g., no therapy, a different therapy,<br />

or Arm or a placebo) This group is compared to the group that<br />

receives the experimental intervention, to see if the<br />

experimental intervention is effective.<br />

Correlation A statistical technique for determining the extent to<br />

which variations in the values of one variable are<br />

associated with variations in the value of another.<br />

39

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!